|
SGEF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.966200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.583800E-03 |
| Normal-vs-Stage2 |
3.241700E-02 |
| Normal-vs-Stage3 |
4.260400E-03 |
| Normal-vs-Stage4 |
3.537900E-03 |
| Stage1-vs-Stage2 |
5.547600E-01 |
| Stage1-vs-Stage3 |
6.632800E-01 |
| Stage1-vs-Stage4 |
3.256200E-01 |
| Stage2-vs-Stage3 |
7.602600E-01 |
| Stage2-vs-Stage4 |
8.683400E-01 |
| Stage3-vs-Stage4 |
5.497000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.038600E-04 |
| Normal-vs-AfricanAmerican |
7.560300E-02 |
| Normal-vs-Asian |
3.863200E-03 |
| Caucasian-vs-AfricanAmerican |
6.448200E-01 |
| Caucasian-vs-Asian |
8.437800E-01 |
| AfricanAmerican-vs-Asian |
7.261200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.190270E-02 |
| Normal-vs-Female |
2.419400E-04 |
| Male-vs-Female |
4.404200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.841200E-04 |
| Normal-vs-Age(41-60Yrs) |
7.003700E-04 |
| Normal-vs-Age(61-80Yrs) |
8.538000E-03 |
| Normal-vs-Age(81-100Yrs) |
7.493700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.639200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.101800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.575710E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.173000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.338000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.986100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.469400E-01 |
| Classical-VS-Follicular |
2.26599999999522E-05 |
| Classical-VS-Other |
2.438000E-01 |
| Classical-VS-Normal |
1.29950000005152E-06 |
| Tall-VS-Follicular |
5.123700E-02 |
| Tall-VS-Other |
4.559000E-01 |
| Tall-VS-Normal |
3.378300E-02 |
| Follicular-VS-Other |
8.155400E-01 |
| Follicular-VS-Normal |
9.860000E-01 |
| Other-VS-Normal |
8.290600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.809900E-02 |
| Normal-vs-N1 |
1.355570E-01 |
| N0-vs-N1 |
9.053000E-01 |
|
|
